Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
Black Marble Capital Management
TaipeiSeed–Late Stage
12 people
CentreStone Ventures
WinnipegPre-Seed–Series A$182.5K – $1.8M
3 people
Diamond Biofund
TaipeiSeed–Series B
6 people
dsm-firmenich Venturing
MaastrichtPre-Seed–Late Stage$108K – $5.4M
9 people
EASO Ventures
DonostiaPre-Seed–Series A$108K – $1.1M
3 people
EMBL Ventures
HeidelbergSeed–Late Stage$108K – $5.4M
Empire State Development – New York Ventures
New YorkPre-Seed–Series B$500K – $1.5M
9 people
Första Entreprenörsfonden AB
DjursholmPre-Seed–Series A$540K
3 people
ID Ventures
SeoulSeed–Series A
Jumar Bioincubator
MelbournePre-Seed–Series A
6 people
Matū
AucklandPre-Seed–Growth
Novellus Ventures Ls1 Gp, Llc
HoustonPre-Seed–Series A
6 people
SBI Investment Korea Co. Ltd.
SeoulSeed–Late Stage$2.5M – $33M
SBI JI Innovation Advisory Ltd.
Tel Aviv-YafoSeed–Series B
6 people
SDL Ventures, LLC
RenoSeed–Series A$500K – $2M
3 people
SODENA
PamplonaSeed–Series B$108K
3 people
VC23 Investors
AvonSeed–Series A
6 people
WARF
MadisonSeed–Series A
6 people
Zen11 Holding
GrazSeries A–Growth
BioScience Ventures Group AG
MunichPre-Seed–Series A$220K – $550K
2 people
Leksell Social Ventures
StockholmPre-Seed–Series A$1M
2 people
Oost NL
ApeldoornSeed–Late Stage$108K – $5.4M
2 people
Claremont Creek Ventures
OaklandSeed–Late Stage$500K – $3M
4 people
iBionext
ParisSeed–Series A
4 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.
















